IL7R and Headache: Furthermore, headache was reported by 5 of the 18 healthy volunteers in a study that investigated the safety of GSK2618960, an IL‐7 receptor‐α subunit (CD127) monoclonal antibody (34), suggesting that dysregulation in the IL-7 levels could be associated with headache.